Valeant Pharmaceuticals International Inc (VRX) - Medical Equipment - Deals and Alliances Profile

Published : Dec-2017

No. of Pages : 157

order by fax Inquire before Buying request discount

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Valeant Pharmaceuticals International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Valeant Pharmaceuticals International Inc, Medical Equipment, Deal Details 16
Asset Purchase 16
Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs 16
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 17
Valeant Pharma to Acquire Dental Whitening Business from Klox Technologies 18
Venture Financing 19
AcuFocus Raises Funds Through Series F Financing 19
Private Equity 21
Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management 21
Water Street Healthcare Partners Acquires OraPharma 22
Partnerships 23
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 23
Namtall Enters into Licensing Agreement with Valeant Pharma 25
Bausch & Lomb Enters Into Licensing Agreement With Cirle 26
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 27
Bausch & Lomb Enters Into Licensing Agreement With UltraVision 28
Swedish Orphan Biovitrum Enters into Distribution Agreement with PharmaSwiss 29
Synergetics USA Enters Into Agreement With Cleveland Clinic To Develop Next Generation Intraoperative Devices 30
Valeant Pharmaceuticals International Partners With Living Proof 31
Obagi Medical Products Extends Distribution Agreement With Suneva Medical 32
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 33
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 34
Obagi Medical Products Enters Into Distribution Agreement With Suneva Medical For ReGenica Facial Rejuvenation Complex 35
Solta Medical Expands Co-Marketing Agreement With SkinCeuticals 36
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 37
Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 38
Solta Medical Enters Into Co-Marketing Agreement With SkinCeuticals 39
OrthoScan Enters Into Distribution Agreement With Ziehm Imaging 40
Unilens Vision Enters Into Distribution Agreement With No. 7 Contact Lens Lab 41
Bausch & Lomb Enters Into Distribution Agreement With Technolas Perfect Vision 42
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 43
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 44
Equity Offering 45
Bausch & Lomb Withdraws IPO 45
Solta Medical Completes Public Offering Of Common Stock For US$17 Million 47
Synergetics USA Files Registration Statement For Public Offering To Raise Up To US$50 Million 48
Debt Offering 49
Valeant Pharma Prices Private Placement of 9% Notes Due 2025 for USD1.18 Billion 49
Valeant Pharma Raises USD591.4 Million in Private Placement of 5.5% Notes Due 2025 50
Valeant Pharma Raises USD801.4 Million in Private Placement of Notes 51
Valeant Pharma Raises USD1.5 Billion in Public Offering of 7% Notes Due 2024 52
Valeant Pharma Raises USD1 Billion in Public Offering of 6.5% Notes Due 2022 53
Solta Medical Completes Private Placement Of Debt Securities For US$40 Million 54
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$1.75 Billion 55
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$500 Million 56
Valeant Pharma International Completes Private Placement Of Senior Unsecured Notes Due 2016 For US$950 Million 57
Valeant Pharma International Completes Private Placement Of Senior Unsecured Notes Due 2022 For US$550 Million 59
Valeant Pharma Completes Private Placement Of 6.75% Senior Unsecured Notes Due 2021 For US$650 Million 61
Asset Transactions 62
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 62
Valeant Pharma May Sell its Eye-Surgery Equipment Business for up to USD2.5 Billion 63
Almirall Plans to Acquire Dermatology Assets from Valeant Pharmaceuticals 64
Stryker Acquires Neuro Portfolio Assets of Synergetics 65
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 66
Medicis Pharma Plans Sale Of LipoSonix Device 67
Acquisition 68
Valeant Pharma to Sell Sprout Pharma 68
Pershing Square Capital Management Sells its Investment in Valeant Pharma 69
Bausch & Lomb Acquires Doctor's Allergy Formula 70
Valeant Pharma Acquires Synergetics 71
Valeant Pharma to Acquire Unilens Vision 73
Valeant Canada Acquires CROMA Pharma Canada 74
Valeant Pharma Completes Acquisition Of Solta Medical For US$250 Million 75
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 77
Synergetics USA Acquires M.I.S.S. Ophthalmics For US$3 Million 79
OlainFarm Acquires Additional 23.37% Stake In Silvanols, Pharma Products Manufacturer 80
Valeant Pharma Acquires Croma-Pharma Polska And Croma Romania From Croma-Pharma 81
Solta Medical Completes Acquisition Of Sound Surgical For Up To US$40 Million 82
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 83
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 85
Jelfa Acquires Emo-Farm From ICN Polfa Rzeszow For US$10 Million 87
Valeant Pharma Completes Acquisition Of Orapharma From Water Street Healthcare Partners For US$442 Million 88
Bausch & Lomb Acquires Laboratorio Pfortner Cornealent SACIF 90
Solta Medical Acquires Medicis Technologies From Medicis Pharma 91
ATON Acquires 100% Stake In OrthoScan 92
Valeant Pharmaceuticals International Inc - Key Competitors 93
Valeant Pharmaceuticals International Inc - Key Employees 94
Valeant Pharmaceuticals International Inc - Locations And Subsidiaries 95
Head Office 95
Other Locations & Subsidiaries 95
Recent Developments 104
Financial Announcements 104
Nov 07, 2017: Valeant Announces Third-Quarter 2017 Results 104
Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 106
May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range 109
Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance 110
Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results 114
Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results 117
Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results 119
Mar 15, 2016: Valeant Pharmaceuticals Reports Preliminary Unaudited Fourth Quarter 2015 Financial Information 121
Corporate Communications 122
Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts 122
Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International 123
Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications 124
Jun 19, 2017: John Paulson Joins Valeant Board Of Directors 125
May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership 126
Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors 127
Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology 128
Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer 129
Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer 130
Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team 131
Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors 133
Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director 134
May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller 135
May 03, 2016: Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals 136
Apr 29, 2016: Valeant Announces Nominees For Election To Board Of Directors 137
Apr 25, 2016: Valeant Names Joseph C. Papa To Be Chairman And Chief Executive Officer Of Valeant Pharmaceuticals 139
Mar 21, 2016: Valeant Announces CEO Succession Plan And Changes To Board Of Directors 140
Mar 09, 2016: Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board 141
Mar 02, 2016: Valeant Pharmaceuticals Announces Management Change 143
Feb 28, 2016: Valeant Pharmaceuticals Announces Management And Business Update 144
Legal and Regulatory 145
Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation 145
Mar 09, 2016: Valeant And R&O Pharmacy End Litigation 146
Government and Public Interest 147
Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme 147
Product News 149
May 22, 2017: Bausch + Lomb Introduces renu Advanced Formula Multi-Purpose Solution 149
Other Significant Developments 150
Nov 15, 2017: Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program 150
Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations 151
May 16, 2016: Valeant Pharmaceuticals Provides Update on Regulatory Matters 152
Apr 13, 2016: Valeant Pharmaceuticals Provides Update Regarding Regulatory Matters 153
Mar 21, 2016: Valeant Provides Accounting And Financial Reporting Update 154
Appendix 157
Methodology 157
About GlobalData 157
Contact Us 157
Disclaimer 157

List of Tables
Valeant Pharmaceuticals International Inc, Medical Equipment, Key Facts, 2016 2
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Valeant Pharmaceuticals International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Valeant Pharmaceuticals International Inc, Deals By Market, 2011 to YTD 2017 11
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs 16
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 17
Valeant Pharma to Acquire Dental Whitening Business from Klox Technologies 18
AcuFocus Raises Funds Through Series F Financing 19
Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management 21
Water Street Healthcare Partners Acquires OraPharma 22
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 23
Namtall Enters into Licensing Agreement with Valeant Pharma 25
Bausch & Lomb Enters Into Licensing Agreement With Cirle 26
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 27
Bausch & Lomb Enters Into Licensing Agreement With UltraVision 28
Swedish Orphan Biovitrum Enters into Distribution Agreement with PharmaSwiss 29
Synergetics USA Enters Into Agreement With Cleveland Clinic To Develop Next Generation Intraoperative Devices 30
Valeant Pharmaceuticals International Partners With Living Proof 31
Obagi Medical Products Extends Distribution Agreement With Suneva Medical 32
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 33
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 34
Obagi Medical Products Enters Into Distribution Agreement With Suneva Medical For ReGenica Facial Rejuvenation Complex 35
Solta Medical Expands Co-Marketing Agreement With SkinCeuticals 36
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 37
Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 38
Solta Medical Enters Into Co-Marketing Agreement With SkinCeuticals 39
OrthoScan Enters Into Distribution Agreement With Ziehm Imaging 40
Unilens Vision Enters Into Distribution Agreement With No. 7 Contact Lens Lab 41
Bausch & Lomb Enters Into Distribution Agreement With Technolas Perfect Vision 42
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 43
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 44
Bausch & Lomb Withdraws IPO 45
Solta Medical Completes Public Offering Of Common Stock For US$17 Million 47
Synergetics USA Files Registration Statement For Public Offering To Raise Up To US$50 Million 48
Valeant Pharma Prices Private Placement of 9% Notes Due 2025 for USD1.18 Billion 49
Valeant Pharma Raises USD591.4 Million in Private Placement of 5.5% Notes Due 2025 50
Valeant Pharma Raises USD801.4 Million in Private Placement of Notes 51
Valeant Pharma Raises USD1.5 Billion in Public Offering of 7% Notes Due 2024 52
Valeant Pharma Raises USD1 Billion in Public Offering of 6.5% Notes Due 2022 53
Solta Medical Completes Private Placement Of Debt Securities For US$40 Million 54
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$1.75 Billion 55
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$500 Million 56
Valeant Pharma International Completes Private Placement Of Senior Unsecured Notes Due 2016 For US$950 Million 57
Valeant Pharma International Completes Private Placement Of Senior Unsecured Notes Due 2022 For US$550 Million 59
Valeant Pharma Completes Private Placement Of 6.75% Senior Unsecured Notes Due 2021 For US$650 Million 61
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 62
Valeant Pharma May Sell its Eye-Surgery Equipment Business for up to USD2.5 Billion 63
Almirall Plans to Acquire Dermatology Assets from Valeant Pharmaceuticals 64
Stryker Acquires Neuro Portfolio Assets of Synergetics 65
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 66
Medicis Pharma Plans Sale Of LipoSonix Device 67
Valeant Pharma to Sell Sprout Pharma 68
Pershing Square Capital Management Sells its Investment in Valeant Pharma 69
Bausch & Lomb Acquires Doctor's Allergy Formula 70
Valeant Pharma Acquires Synergetics 71
Valeant Pharma to Acquire Unilens Vision 73
Valeant Canada Acquires CROMA Pharma Canada 74
Valeant Pharma Completes Acquisition Of Solta Medical For US$250 Million 75
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 77
Synergetics USA Acquires M.I.S.S. Ophthalmics For US$3 Million 79
OlainFarm Acquires Additional 23.37% Stake In Silvanols, Pharma Products Manufacturer 80
Valeant Pharma Acquires Croma-Pharma Polska And Croma Romania From Croma-Pharma 81
Solta Medical Completes Acquisition Of Sound Surgical For Up To US$40 Million 82
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 83
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 85
Jelfa Acquires Emo-Farm From ICN Polfa Rzeszow For US$10 Million 87
Valeant Pharma Completes Acquisition Of Orapharma From Water Street Healthcare Partners For US$442 Million 88
Bausch & Lomb Acquires Laboratorio Pfortner Cornealent SACIF 90
Solta Medical Acquires Medicis Technologies From Medicis Pharma 91
ATON Acquires 100% Stake In OrthoScan 92
Valeant Pharmaceuticals International Inc, Key Competitors 93
Valeant Pharmaceuticals International Inc, Key Employees 94
Valeant Pharmaceuticals International Inc, Other Locations 95
Valeant Pharmaceuticals International Inc, Subsidiaries 95

List of Figures
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 2
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 2
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 2
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 2
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 9
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Valeant Pharmaceuticals International Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 11

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Valeant Pharmaceuticals International Inc (VRX) - Medical Equipment - Deals and Alliances Profile

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027